Recurrent Parotid Carcinosarcoma in an Asymptomatic Patient by Joshua Mansour MD, Abhishek Mangaonkar MBBS, Vamsi Kota MBBS

Get full text

Pneumatosis Intestinalis in a Patient with Acute Promyelocytic Leukemia by Abhishek Mangaonkar, Joshua Mansour, Ryan Keen, Tarun Kukkadapu, Rohini Chintalapally, Vamsi Kota

Get full text

CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases by Rimal Ilyas, Kristen McCullough, Talha Badar, Mrinal M. Patnaik, Hassan Alkhateeb, Abhishek Mangaonkar, Animesh Pardanani, Ayalew Tefferi, Naseema Gangat

Get full text

ERRATUM: Managing acute promyelocytic leukemia in patients belonging to the Jehovah’s Witness congregation by Martha L. Arellano, Anand P. Jillella, Leonard T. Heffner, Manila Gaddh, Amelia A. Langston, Hanna J. Khoury, Abhishek Mangaonkar, Vamsi K. Kota

Get full text

P709: H2AK119UB IN THE TRANSCRIPTIONAL REGULATION OF PATIENTS WITH ASXL1-MUTANT CHRONIC MYELOMONOCYTIC LEUKEMIA by Moritz Binder, Liguo Wang, Stephanie Safgren, Jeong-Heon Lee, Terra Lasho, Christy Finke, Jenna Fernandez, Abhishek Mangaonkar, Alexandre Gaspar-Maia, Mrinal Patnaik

Get full text

Immune-Mediated Autonomic Neuropathies following Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia by Abhishek Mangaonkar, Hassan Al Khateeb, Narjust Duma, Erik K. St. Louis, Andrew McKeon, Mrinal Patnaik, William Hogan, Mark Litzow, Taxiarchis Kourelis

Get full text

Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia by Naseema Gangat, Isla Johnson, Kristen McCullough, Faiqa Farrukh, Aref Al-Kali, Hassan Alkhateeb, Kebede Begna, Abhishek Mangaonkar, Mark Litzow, William Hogan, Mithun Shah, Mrinal Patnaik, Animesh Pardanani, Ayalew Tefferi

Get full text

P1346: THE IMPACT OF CYTOTOXIC THERAPY ON THE RISK OF PROGRESSION AND DEATH IN PATIENTS WITH CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE. by LI Marissa, Anmol Baranwal, Syed Shah, Mark Gurney, Al-Kali Aref, Alkhateeb Hassan, Foran James, Cecilia Arana Yi, Dong Chen, Abhishek Mangaonkar, Kristen Mccoullough, Ayalew Tefferi, Mrinal Patnaik, Mithun Shah

Get full text

Outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapy by Naseema Gangat, Rimal Ilyas, Isla M Johnson, Kristen McCullough, Aref Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Abhishek Mangaonkar, Mark R Litzow, William Hogan, Mithun Shah, Mrinal M Patnaik, Animesh Pardanani, Ayalew Tefferi

Get full text

P580: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH WT1 MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE by Rami Basmaci, Anmol Baranwal, Rong He, David Viswanatha, Patricia Greipp, James M Foran, Cecilia Arana Yi, Mithun Shah, Abhishek Mangaonkar, Mark Litzow, William Hogan, Kebede Benga, Antoine Saliba, Naseema Gangat, Ayalew Tefferi, Mrinal Patnaik, Aref Al-Kali, Hassan Alkhateeb

Get full text

Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience by Ayalew Tefferi, Naseema Gangat, Mithun Shah, Hassan Alkhateeb, Mrinal S. Patnaik, Aref Al-Kali, Michelle A. Elliott, William J. Hogan, Mark R. Litzow, Christopher C. Hook, Abhishek Mangaonkar, David Viswanatha, Dong Chen, Animesh Pardanani, Rhett P. Ketterling, Kebede H. Begna

Get full text

U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity by Talha Badar, Yenny A. Moreno Vanegas, Ahmad Nanaa, James M. Foran, Aref Al-Kali, Abhishek Mangaonkar, Hemant Murthy, Hassan B. Alkhateeb, David Viswanatha, Rong He, Mithun Shah, Cecilia Arana Yi, Mark R. Litzow, Naseema Gangat, Ayalew Tefferi, Mrinal M. Patnaik

Get full text

P734: CLONAL HEIRARCHY AND HETEROGENEITY IN STAG2M MYELOID NEOPLASMS: THE MAYO CLINIC EXPERIENCE by Bahga Katamesh, Ahmad Nanaa, Rong He, David Viswanatha, Patricia Greipp, Phuong Nguyen, Dragan Jevremovic, Cecilia Arana Yi, James M Foran, Kebede Benga, Naseema Gangat, Abhishek Mangaonkar, Antoine Saliba, Mrinal Patnaik, William Hogan, Mark Litzow, Ayalew Tefferi, Mithun Shah, Hassan Alkhateeb, Aref Al-Kali

Get full text

Adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival by Ayalew Tefferi, Amritpal Singh, Naseema Gangat, Aref Al-Kali, Hassan Alkhateeb, Mithun Shah, Mrinal S. Patnaik, Michelle A. Elliott, William J. Hogan, Mark R. Litzow, Alexandra Wolanskyj-Spinner, Christopher C. Hook, Abhishek Mangaonkar, David Viswanatha, Dong Chen, Animesh Pardanani, Kebede H. Begna, Rhett P. Ketterling

Get full text

P747: CLINICAL CHARACTERISTICS AND OUTCOME OF EZH2-MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE by Muhamad Oum, Ahmad Nanaa, Amrutha Mittapalli, Rong He, David Viswanatha, Patricia Greipp, Phuong Nguyen, Dragan Jevremovic, Cecilia Arana Yi, James M Foran, Kebede Benga, Naseema Gangat, Abhishek Mangaonkar, Antoine Saliba, Mrinal Patnaik, William Hogan, Mark Litzow, Ayalew Tefferi, Mithun Shah, Hassan Alkhateeb, Aref Al-Kali

Get full text

Prognostic impact of <i>SF3B1</i> mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases by Faiqa Farrukh, Maymona Abdelmagid, Abhishek Mangaonkar, Mrinal Patnaik, Aref Al-Kali, Michelle A. Elliott, Kebede H. Begna, Christopher C. Hook, William J. Hogan, Animesh Pardanani, Mark R. Litzow, Rhett P. Ketterling, Naseema Gangat, Daniel A. Arber, Attilio Orazi, Rong He, Kaaren Reichard, Ayalew Tefferi

Get full text

P722: CHARACTERISATION OF PHF6 MUTATIONS IN MYELOID NEOPLASMS: THE MAYO CLINIC EXPERIENCE by Amrutha Sai Mittapalli, Bahga Katamesh, Muhamad Oum, Rong He, David Viswanatha, Patricia Greipp, Phuong Nguyen, Dragan Jevremovic, Cecilia Arana Yi, James M Foran, Kebede Benga, Naseema Gangat, Abhishek Mangaonkar, Antoine Saliba, Mrinal Patnaik, William J Hogan, Mark Litzow, Ayalew Tefferi, Mithun Shah, Hassan Alkhateeb, Aref Al-Kali

Get full text

Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blastphase myeloproliferative neoplasm by Naseema Gangat, Rimal Ilyas, Kristen McCullough, Kebede H. Begna, Aref Al-Kali, Mrinal M. Patnaik, Mark R. Litzow, William J. Hogan, Abhishek Mangaonkar, Hassan Alkhateeb, Mithun V. Shah, Michelle A. Elliott, James M. Foran, Talha Badar, Jeanne M. Palmer, Curtis A. Hanson, Animesh Pardanani, Ayalew Tefferi

Get full text

Molecular predictors of response and survival following IDH1/2 inhibitor monotherapy in acute myeloid leukemia by Naseema Gangat, Kristen McCullough, Maymona Abdelmagid, Omer Karrar, Marissa Powell, Aref Al-Kali, Hassan Alkhateeb, Kebede Begna, Abhishek Mangaonkar, Antoine Saliba, Mehrdad Hefazi Torghabeh, Mark Litzow, William Hogan, Mithun Shah, Mrinal Patnaik, Animesh Pardanani, Talha Badar, James Foran, Jeanne Palmer, Lisa Sproat, Cecilia Arana Yi, Ayalew Tefferi

Get full text

Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) by Mostafa Abdallah, Kristen McCullough, Rimal Ilyas, Kebede H. Begna, Aref Al-Kali, Mark R. Litzow, William J. Hogan, Abhishek Mangaonkar, Hassan Alkhateeb, Mithun V. Shah, Michelle A. Elliott, James M. Foran, Talha Badar, Jeanne M. Palmer, Cecilia Arana Yi, Lisa Sproat, Animesh Pardanani, Mrinal M. Patnaik, Horatiu Olteanu, Rhett P. Ketterling, Ayalew Tefferi, Naseema Gangat

Get full text